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ABSTRACT 
The initial impact of spinal cord injury (SCI) often results in inflammation leading to irre-
versible damage with consequent loss of locomotor function. Minimal recovery is achieved 
once permanent damage has occurred. Using a mouse model of SCI we observed a transitory 
increase followed by a rapid decline in gene expression and protein levels of nuclear factor 
erythroid 2-related factor 2 (Nrf2), a master regulator of cellular anti-oxidative genes. Imme-
diate treatment with diarylpropionitrile (DPN), a non-steroidal selective estrogen receptor β 
ligand, resulted in a significant increase in Nrf2 levels, and reduction of inflammation and 
apoptosis compared to untreated SCI animals. Furthermore, DPN-treatment improved loco-
motor function within 7 days after induction of SCI. DPN acted through activation of PI3K/ 
Akt pathway, known to be involved in down-regulation of apoptosis and up-regulation of cell 
survival in injured tissues. These findings suggest that immediate activation of cellular anti-
oxidative stress mechanisms should provide protection against irreversible tissue damage and 
its profound detrimental effect on locomotor function associated with SCI. 
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INTRODUCTION 
Pathogenesis of spinal cord injury (SCI) 
is characterized as being biphasic, consisting 
of primary injury which causes the initial 
spinal cord trauma and is considered irre-
versible, and secondary injury which refers 
to the molecular and biochemical events that 
occur following the primary injury (Rowland 
et al., 2008). Earlier studies suggested that 
local inflammatory response and oxidative 
stress following SCI are the major contribu-
tors to further damage (David et al., 2012). 
Thus resident microglia in the central nerv-
ous system as well as infiltrating macro-
phages from the periphery may further con-
tribute to inflammation by releasing pro-
inflammatory cytokines, such as interleukin-
1β (IL-1β), as well as building up reactive 
oxygen species (ROS) (Pajoohesh-Ganji and 
Byrnes, 2011). Inflammatory response re-
sulting from astrogliosis around the injury 
site inhibits the tissue repair process (Rolls et 
al., 2009), and the primary function of neu-
roprotection after SCI is to counteract the 
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mechanisms of inflammation and oxidative 
stress to minimize their pathological effects. 
One mechanism of neural repair and preven-
tion of cell death is via the estrogen signaling 
pathway through binding to estrogen recep-
tors ERα or ERβ for the activation of down-
stream kinases, such as PI3K/Akt. Treatment 
of SCI with 17β-estradiol, which binds to 
both ERα and ERβ, attenuates the inflamma-
tory response and reduces neuronal cell 
death (Tiwari-Woodruff et al., 2007). 
Diarylpropionitrile (DPN) (2,3-bis(4-hy-
droxyphenyl)-propionitrile), a non-steroidal 
selective high affinity ligand of ERβ (80-300 
folds over ERα) (Carroll et al., 2012), has 
neuroprotective effects in a number of neuro-
logical diseases (Kumar et al., 2013). DPN 
has been shown to exert anti-inflammatory 
role in neuroprotection by attenuating in-
flammatory cytokines IL-1β and IL-6 ex-
pression in mouse brain during neuroin-
flammation (Brown et al., 2010). DPN also 
increases the expression of a panel of bioen-
ergetic enzymes and antioxidant proteins in 
primary rat cultured hippocampal neurons 
(Irwin et al., 2012). Nuclear factor erythroid 
2-related factor 2 (Nrf2) has been recognized 
for its role in detoxification during the build-
up of ROS and in the activation of phase II 
anti-oxidative genes in a number of CNS 
diseases and disorders (Zhang et al., 2013), 
as well as in traumatic brain injury (Jin et al., 
2008, 2009) and SCI (Mao et al., 2010; 
Wang et al., 2012). In this study, we exam-
ined the ameliorating effects of DPN in mice 
from the early stage of SCI up to 7 days by 
measuring the mRNA expressions and pro-
tein levels of Nrf2 and of proteins involved 
in inflammation, apoptosis, and the pathway 
related to DPN neuroprotection for SCI. 
 
MATERIALS AND METHODS 
Animals and preparation of SCI 
A total of 114 C57Bl/6 female 3-5 
month-old mice (30-35 g) were supplied by 
the Department of Laboratory Animal Medi-
cine, UCLA. These mice were housed at 20-
22 °C, in relative humidity of 40-60 %, and 
with illumination from 6 a.m. to 6 p.m. and 
allowed ad libitum access to food and water. 
The standard environmental enrichment for 
mice included social housing (3 animals/ 
cage) in traditional wire-topped cages 
(800 cm2) with 1-cm layer of wood chip 
bedding. Animal care, handling and treat-
ments were carried out according to the rules 
and regulations of UCLA Animal Research 
Committee and Department of Laboratory 
Animal Medicine. Mice were anesthetized 
with inhalation of isoflurane in oxygen-rich 
air. After dorsal midline incision and expo-
sure of the lumbar vertebrae, laminectomy 
was performed at the L1/L2 level to expose 
the spinal cord. Moderate crush SCI was 
made using No.5 Dumont forceps (Fine Sci-
ence Tools) ground down to a tip width of 
0.4 mm and modified with a spacer so that at 
maximal closure a 0.4 mm space remained 
(Faulkner et al., 2004). The behavior was 
tested before and every 24 h after performing 
SCI. 
 
Drug administration 
After induction of SCI, animals were 
immediately subcutaneously injected lateral-
ly to the injury site with 8 mg DPN (Tocris 
Bioscience, Ellisville, MO)/kg of body 
weight (Tiwari-Woodruff et al., 2007), or 
with vehicle (Miglyol 812 N liquid oil; gift 
from Sasol North America, Houston, TX) 
and this treatment was repeated every 24 h 
until tissue collection. Normal mice were 
used as controls for comparison with DPN-
treated and -untreated SCI animals. Tissue 
samples from three mice for each experiment 
were collected at 6, 12, 24, 48, 72 h and 7 
days after induction of SCI.  
 
Nrf2 and IL-1β mRNA expression in the 
injured spinal cord of mice as detected by 
Real-Time PCR 
The region of injured spinal cord tissue 
was dissected, immediately frozen in liquid 
nitrogen and stored at -80 °C until processed. 
Total tissue RNA was prepared using RNe-
asy Mini kit (Qiagen, CA) and cDNA syn-
thesis was performed using RETROscript® 
reverse transcription kit (Ambion, TX) as 
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previously described (Kumar et al., 2009). 
Quantitative (q)-PCR was conducted in 
SsoAdvancedTM SYBR® Green Supermix 
(Bio-Rad, CA) containing 300 nM of each of 
the following primers; Cyclophilin A (PPIA) 
forward: 5’-CGAGCTGTTTGCAGACAAA 
G-3’ and reverse 5’-TCTGTGAAAGGAGG 
AACCCTTA-3’ primers; Nrf2 forward 5’-
TGGAGAACATTGTCGAGCTG-3’ and re-
verse 5’-CCGCCTTTTCAGTAGATGGA-3’ 
primers; or IL-1β forward 5’-GTGAAATG 
CCACCTTTTGACA-3’; and reverse 5’CAA 
AGGTTTGGAAGCAGCC-3’ primers (Ku-
mar et al., 2009). Thermocycling (CFX96, 
Bio-Rad, CA) of triplicate samples was per-
formed as follows: 5 min at 95 °C; 45 cycles 
of 30 s at 95 °C, 30 s at 60 °C and 30 s at 
72 °C; followed by a melting curve analysis 
of 1 min at 95 °C, 1 min at 55 °C, 60 cycles 
of 5 s with temperature increase of 0.5 °C/ 
cycle starting from 65 °C to 95 °C. The ex-
pression level of the gene of interest was 
normalized to that of PPIA using the formula 
2-∆∆CT. The results were analyzed using Bio-
Rad CFX manager software (Bio-Rad, CA). 
 
Nrf2, IL-1β, activated caspase-3, PI3K and 
Akt protein expression in the injured spinal 
cord of mice as detected by Western blot 
analysis 
Equal amounts of protein from tissue ly-
sate were separated on 10 % SDS-PAGE un-
der reducing condition, and transferred onto 
polyvinylidene fluoride membranes. The 
membranes were incubated with 1:1000 rab-
bit anti-Nrf2 (GeneTex), 1:200 rabbit anti-
IL-1β (Santa Cruz), 1:500 rabbit anti-PI3K,  
-p-PI3K, -Akt, and -p-Akt (Cell Signaling), 
1:200 rabbit anti-activated caspase-3 
(Chemicon), or 1:20000 mouse anti-GAPDH 
(Ambion), and then incubated with a HRP-
conjugated secondary antibody (Zymed). 
The signal was detected with ECL Western 
blotting substrate (Bio-Rad) and captured on 
HyperfilmTM (Amersham Pharmacia Bio-
tech). 
Score of locomotor function of mouse hind 
limbs 
Recovery of locomotor function was 
evaluated to assess the gross voluntary use of 
the hind limbs using open field locomotor 
test every 24 h after SCI induction. The be-
havior of animals was observed for 5 min by 
three individuals blinded to the experimental 
conditions. A simple six-point scale was 
used, which is found to be more appropriate 
for the model of upper lumbar SCI 
(Herrmann et al., 2008), and animals re-
ceived a score for voluntary movement of 
each hind limb. In brief, the scale involves 
closely monitoring limb movement, weight-
bearing capability, coordinated and proper 
gait, movement in all joints of the hind limb, 
full weight support and appropriate limb po-
sition. Left and right hind limbs were scored 
separately and averaged. 
 
Statistical analysis 
Data were expressed as mean ± SEM. 
Statistical analysis was performed using one-
way analysis of variance (ANOVA) fol-
lowed by Student-Newman-Keul’s post hoc 
test. P < 0.05 is considered statistically sig-
nificant different among control, SCI, and 
DPN-treated groups. 
 
RESULTS 
Gene expression of Nrf2, involved in de-
toxifying ROS, was detected in mouse spinal 
cord tissues within 12 h after SCI, then con-
tinuously declined after 24 h until day 7 
(Figure 1A) and treatment with DPN resulted 
in enhancing Nrf2 gene expression, starting 
from 6 h up to day 7. There is a concomitant 
significant elevation of Nrf2 protein levels 
from 24 h to day 7 compared to non DPN-
treated SCI group (Figure 1B). After 6 h post 
SCI, increased mRNA and protein levels of 
IL-1β were detected in spinal cord tissues 
compared with normal controls. With DPN 
treatment, IL-1β mRNA (Figure 1C) and 
protein (Figure 1D) levels significantly de-
cline after 6 h and 12 h respectively. Similar-
ly, levels of the apoptosis protein, activated 
caspase-3, show a significant increase in SCI 
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group compared to normal control, starting 
from 6 h to day 7, which was attenuated by 
DPN treatment after 24 h (Figure 2). After 
12 h following SCI, phosphorylated-PI3K 
(p-PI3K) and phosphorylated-Akt (p-Akt) 
levels are significantly higher in DPN-
treated mice compared to untreated SCI 
group (Figure 3). As for the open field loco-
motor test, DPN-treated SCI mice show sig-
nificant elevation of locomotor score after 
48 h compared to untreated SCI group and 
continuously improved till the end of the test 
period (Figure 4). 
 
Figure 1: Neuroprotective effects of DPN in activation of Nrf2 following SCI. DPN can significantly elevate Nrf2 
mRNA (A) and protein (B) levels. DPN treatment also attenuates inflammatory cytokine, IL-1β, mRNA (C) and 
protein (D) levels induced by SCI. Results are expressed as mean ± SEM of 3 independent experiments.  
* p < 0.05, ** p < 0.01, *** p < 0.001 compared to normal control; # p < 0.05, ## p < 0.01, ### p <0.001 compared 
to SCI group.  
 
 
 
 
 
 
 
 
 
Figure 2: DPN protects spinal cord tissue against SCI-
induced apoptosis. Treatment of DPN significantly 
reduces activated caspase-3 level after 24 h following 
SCI induction. The results are expressed as mean ± 
SEM of 3 independent experiments. * p < 0.05,  
** p < 0.01, *** p < 0.001 compared to normal control; 
# p < 0.05, ## p < 0.01 compared to SCI group.  
 
Figure 3: DPN treatment significantly activates phos-
phorylation of PI3K (A) and Akt (B) after 12 h following 
SCI. The results are expressed as mean ± SEM of 3 
independent experiments. * p < 0.05, ** p < 0.01,  
*** p < 0.001 compared to normal control; # p < 0.05, 
## p < 0.01, ### p < 0.001 compared to SCI group.  
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Figure 4: DPN effects on recovery of hind limb loco-
motor function after SCI. Locomotor recovery as 
measured by open field locomotor score. Animals 
were evaluated daily after SCI for 7 days. The results 
are expressed as mean ± SEM of 3 independent ex-
periments. * p < 0.05, ** p < 0.01 compared to normal 
control; # p < 0.05, ## p < 0.01 compared to SCI 
group. 
 
DISCUSSION 
In this study, we demonstrate that oxida-
tive stress and inflammation (as evidenced 
by transient induction of anti-oxidative Nrf2 
gene expression and a more sustained stimu-
lation of inflammatory cytokine IL-1β 
mRNA and protein levels) occurred within 
6-12 hours from the induction of SCI, which 
induced neuronal apoptotic death and dys-
function in open field locomotor activity. 
Treatment with DPN, a ligand of ERβ, im-
mediately following SCI resulted in eleva-
tion of Nrf2 level, attenuation of IL-1β and 
activated caspase-3 levels, and improvement 
of locomotor function. Wang et al. (2012) 
have demonstrated that Nrf2-deficient mice 
are more susceptible to oxidative stress and 
show more severe neurological dysfunctions 
and spinal cord edema after SCI. Moreover, 
administration of Nrf2-activator sulfor-
aphane provides a neuroprotective effect in 
SCI rats (Benedict et al., 2012). Sribnick et 
al. (2005) demonstrated that estrogen treat-
ment in SCI rats attenuated inflammatory 
response by reducing the levels of IL-1β and 
NF-κB. Kumar et al. (2013) showed a de-
crease in activated caspase-3 after DPN 
treatment in experimental autoimmune en-
cephalomyelitis mice and that DPN increases 
oligodendrocyte progenitor cell numbers and 
improves myelination. The improvement in 
locomotor function in DPN-treated SCI mice 
in our study was similar to that reported with 
estrogen (Sribnick et al., 2010). 
DPN-induced neuroprotection is depend-
ent on kinase activities, including the 
PI3K/Akt signaling pathway (Mannella and 
Brinton, 2006). DPN treatment of SCI mice 
elevated levels of p-PI3K and p-Akt 
compared to untreated SCI animals. 
Activation of PI3K/Akt pathway mediates 
cell survival in a multiple sclerosis animal 
model (Kumar et al., 2013). In addition, 
PI3K/Akt pathway plays a key role in the 
regulation of Nrf2-dependent neuro-
protection by inducing Nrf2 to translocate 
into the nucleus and activate anti-oxidative 
genes (Zhang et al., 2013), and inhibition of 
PI3K with wortmanin attenuates Nrf2 
expression (Zou et al., 2013). Besides its an-
ti-oxidative effects through the activation of 
PI3K/Akt pathway, DPN likely mediates 
neuroprotection against SCI through its di-
rect interaction with ERβ. To clarify whether 
ERβ plays a significant role in the neuropro-
tective effects of DPN, Zhao et al. (2011) 
implemented (R,R)-THC, a specific ERβ in-
hibitor, to confirm that the neuroprotective 
effects of DPN against Aβ1-42 neurotoxicity 
are mediated through ERβ pathway in rat 
cultured hippocampal neurons. The findings 
from this study indicated that the oxidative 
stress, apoptosis and inflammatory processes 
accompanying SCI can, in part, be amelio-
rated by the immediate DPN administration, 
leading to partial restoration of locomotor 
function. 
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